Fig. 4.
The improved immuno-microenvironment and systemic immunity induced by pep-PAMP@PTX. (a) Schematic of the development of tumor model and experiment design. (b,c) Flow cytometry analysis of in vivo lymphocytic infiltration in resected tumors; (b) the contour diagrams and (c) quantification. (d,e) The serum (d) IFN-γ and (e) IL-2 levels of mice determined on day 18.